ReoPro (Abciximab) Drug Information: Uses, Side Effects, Drug ...
Learn about the prescription medication ReoPro (Abciximab), drug uses, dosage, side effects, drug interactions, warnings, and patient labeling.
FATA trial: Comparison between tirofiban and abciximab to promote ...
The FATA trial (Facilitated Angioplasty with Tirofiban or Abciximab) compared myocardial tissue reperfusion associated with high-dose bolus tirofiban to the current standard, abciximab, for patients undergoing primary percutaneous ...
Abciximab (ReoPro)
Abciximab, ReoProT, is the Fab fragment of the chimeric human-murine monoclonal antibody 7E3. Abciximab binds to the glycoprotein (GP) IIb/IIIa receptor of human platelets and inhibits platelet aggregation. Abciximab also binds to the ...
Intracoronary Compared With Intravenous Bolus Abciximab ...
Intracoronary Compared With Intravenous Bolus Abciximab Application in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. The Randomized Leipzig Immediate Percutaneous Coronary ...
Medium term comparison of abciximab and eptifibatide in myocardial ...
Mehta, A.; Passey, R.; Sawhney, JPS; Dhawan, S.; Sachdeva, S.; Mohan, R.; Jaishankar, K.; Sharma, V.; Passey, R.; Mehta, A.; Mantri, RR; Jain, R.; Chopra, VK and Khanna, PK (2003) Medium term comparison of abciximab and eptifibatide in ...
Abciximab
Acute MI combination regimen (unlabeled): Half-dose tenecteplase (15-25 mg based on weight), abciximab 0.25 mg/kg bolus then 0.125 mcg/kg/minute (maximum: 10 mcg/minute) for 12 hours and heparin dosing as follows: Concurrent bolus of 40 ...
Impact of abciximab on coronary restenosis in diabetic patients ...
Acute Cardiac Care.
ReoPro (Abciximab) - updated on RxList
ReoPro (Abciximab) drug description - FDA approved labeling for prescription drugs and medications at RxList.
Prehospital versus periprocedural abciximab in ST -elevation ...
European Journal of Emergency Medicine.
Randomized comparison between tirofiban and abciximab to promote ...
European Heart Journal.